Synthesis and biological evaluation of chromenylurea and chromanylurea derivatives as anti-TNF-α agents that target the p38 MAPK pathway was written by Li, Xingzhou;Zhou, Xinming;Zhang, Jing;Wang, Lili;Long, Long;Zheng, Zhibing;Li, Song;Zhong, Wu. And the article was included in Molecules in 2014.Quality Control of 3-(tert-Butyl)isoxazol-5-amine This article mentions the following:
A series of 1-aryl-3-(2H-chromen-5-yl)urea I (R1 = H, 3-Me, 4-Me) and 1-aryl-3-(chroman-5-yl)urea derivatives II (R1 = 4-Me, 4-F, 4-Cl, etc.) were designed, synthesized and evaluated for their inhibitory activities towards TNF-α production in lipopolysaccharide-stimulated THP-1 cells. The most active compound, II (R1 = 4-NO2) inhibited TNF-α release with an IC50 value of 0.033 μM, which is equipotent to that of BIRB796 (IC50 = 0.032 μM). In the experiment, the researchers used many compounds, for example, 3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9Quality Control of 3-(tert-Butyl)isoxazol-5-amine).
3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9) belongs to isoxazole derivatives. An isoxazolyl group is found in many beta-lactamase-resistant antibiotics, such as cloxacillin, dicloxacillin and flucloxacillin. Isoxazole can be synthesised via a variety of methods. Examples include via a 1,3-dipolar cycloaddition of nitrile oxides with alkynes.Quality Control of 3-(tert-Butyl)isoxazol-5-amine
Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem